Liu S - Search Results

1

5-Fluorouracil enhances the chemosensitivity of gastric cancer to TRAIL via inhibition of the MAPK pathway.

Li H, Lv J, Guo J, Wang S, Liu S, Ma Y, Liang Z, Wang Y, Qi W, Qiu W. Li H, et al. Among authors: liu s. Biochem Biophys Res Commun. 2021 Feb 12;540:108-115. doi: 10.1016/j.bbrc.2021.01.006. Epub 2021 Jan 18. Biochem Biophys Res Commun. 2021. PMID: 33476960

2

Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo.

Zhang H, Sui A, Wang Z, Liu S, Yao R. Zhang H, et al. Among authors: liu s. Int J Mol Med. 2012 Aug;30(2):358-64. doi: 10.3892/ijmm.2012.998. Epub 2012 May 14. Int J Mol Med. 2012. PMID: 22614533

3

Induction of non-small cell lung carcinoma apoptosis using soluble RGD-TRAIL by targeting the integrin receptor of tumor cells.

Yao R, Sui A, Wang Z, Liu S, Zhou Q, Liu X, Zhang H. Yao R, et al. Among authors: liu x, liu s. Mol Med Rep. 2012 Dec;6(6):1355-60. doi: 10.3892/mmr.2012.1071. Epub 2012 Sep 10. Mol Med Rep. 2012. PMID: 22965279

4

Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines.

Xiang J, Qiu W, Wang X, Zhou F, Wang Z, Liu S, Yue L. Xiang J, et al. Among authors: liu s. Oncol Rep. 2013 Apr;29(4):1517-23. doi: 10.3892/or.2013.2253. Epub 2013 Jan 24. Oncol Rep. 2013. PMID: 23354013

5

Construction and expression of an eukaryotic expression vector containing the IER3 gene.

Wang Z, Yu HS, Yao RY, Qiu WS, Yue L, Sui AH, Liu XP, Liu SH. Wang Z, et al. Asian Pac J Cancer Prev. 2013;14(1):507-10. doi: 10.7314/apjcp.2013.14.1.507. Asian Pac J Cancer Prev. 2013. PMID: 23534784 Free article.

6

Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.

Liu X, Wang J, Wang H, Liu S, Liang Y, Lv Z, Zhou Q, Ding W. Liu X, et al. Among authors: liu s. Oncol Rep. 2013 Oct;30(4):1913-9. doi: 10.3892/or.2013.2653. Epub 2013 Aug 2. Oncol Rep. 2013. PMID: 23912708

7

Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel.

Li X, Qiu W, Liu B, Yao R, Liu S, Yao Y, Liang J. Li X, et al. Among authors: liu s, liu b. J Transl Med. 2013 Sep 3;11:204. doi: 10.1186/1479-5876-11-204. J Transl Med. 2013. PMID: 24004449 Free PMC article.

8

CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.

Zhou F, Qiu W, Yao R, Xiang J, Sun X, Liu S, Lv J, Yue L. Zhou F, et al. Among authors: liu s. Med Oncol. 2013 Dec;30(4):726. doi: 10.1007/s12032-013-0726-1. Epub 2013 Sep 12. Med Oncol. 2013. PMID: 24026662

9

Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.

Ding A, Zhao W, Shi X, Yao R, Zhou F, Yue L, Liu S, Qiu W. Ding A, et al. Among authors: liu s. PLoS One. 2013 Dec 16;8(12):e82136. doi: 10.1371/journal.pone.0082136. eCollection 2013. PLoS One. 2013. PMID: 24358147 Free PMC article.

10

FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.

Li X, Yao R, Yue L, Qiu W, Qi W, Liu S, Yao Y, Liang J. Li X, et al. Among authors: liu s. J Cell Mol Med. 2014 May;18(5):811-23. doi: 10.1111/jcmm.12216. Epub 2014 Mar 14. J Cell Mol Med. 2014. PMID: 24628949 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78,383 results

Search Page

Filters